Published in Biochim Biophys Acta on April 16, 1991
Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol (1997) 7.14
Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol (2009) 4.99
Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 3.27
Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility. Mol Cell Biol (1993) 2.71
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev (2010) 2.21
Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin. J Cell Biol (1994) 2.08
The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol (2000) 2.07
Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol (2003) 1.94
Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br J Cancer (1993) 1.53
Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. Mol Biol Cell (2000) 1.31
Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum. Mol Biol Cell (1998) 1.29
Rho and Rab small G proteins coordinately reorganize stress fibers and focal adhesions in MDCK cells. Mol Biol Cell (1998) 1.25
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol (1993) 1.19
Tumor cell migration in complex microenvironments. Cell Mol Life Sci (2012) 1.16
Regulation of E-cadherin: does hypoxia initiate the metastatic cascade? Mol Pathol (1999) 1.11
Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J (2003) 1.10
Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction. Clin Exp Metastasis (1998) 1.08
Villin enhances hepatocyte growth factor-induced actin cytoskeleton remodeling in epithelial cells. Mol Biol Cell (2003) 1.02
Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br J Cancer (1996) 0.97
Role of the microtubular system in morphological organization of normal and oncogene-transfected epithelial cells. Proc Natl Acad Sci U S A (1994) 0.88
c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells. Clin Exp Metastasis (2003) 0.87
Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling. J Clin Invest (1993) 0.87
Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression. Mol Med Rep (2015) 0.86
Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMP. Biochem J (2005) 0.85
Biological influence of Hakai in cancer: a 10-year review. Cancer Metastasis Rev (2012) 0.83
Serum hepatocyte growth factor and cancer mortality in an apparently healthy Japanese population. J Epidemiol (2012) 0.81
The mechanism of mononuclear cell infiltration in oral lichen planus: the role of cytokines released from keratinocytes. J Clin Immunol (2000) 0.79
Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br J Cancer (1999) 0.79
Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events. Clin Exp Metastasis (1999) 0.78
Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells. Am J Pathol (1996) 0.78
Gangliosides regulate tumor cell adhesion to collagen. Clin Exp Metastasis (2003) 0.76
Growth factor induced proliferation, migration, and lumen formation of rat endometrial epithelial cells in vitro. J Reprod Dev (2016) 0.76
Identification and characterization of motility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis. Clin Exp Metastasis (1997) 0.75
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (1987) 6.26
Scatter factor/hepatocyte growth factor is essential for liver development. Nature (1995) 5.91
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol (1996) 3.15
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol (1998) 3.05
Structural repertoire of the human VH segments. J Mol Biol (1992) 2.06
The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 beta-lactamase. J Mol Biol (1999) 2.00
Original and artificial antibodies. Nature (1992) 1.97
Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol (1995) 1.79
Hepatocytes and scatter factor. Nature (1990) 1.77
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem (1999) 1.58
Mutation and selection during the secondary response to 2-phenyloxazolone. Proc Natl Acad Sci U S A (1991) 1.35
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci (1994) 1.29
Epithelial scatter factor and development of the chick embryonic axis. Development (1990) 1.28
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J (2001) 1.28
The structural repertoire of the human V kappa domain. EMBO J (1995) 1.26
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development (1995) 1.25
Non-random features of the repertoire expressed by the members of one V kappa gene family and of the V-J recombination. Eur J Immunol (1992) 1.15
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Nat Struct Biol (1999) 1.14
Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains. J Mol Biol (2007) 1.12
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr Biol (1998) 1.10
Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis. Dev Genet (1996) 1.07
Patients' perception of public, voluntary and private dispensaries in rural areas of Tanzania. East Afr Med J (1996) 1.04
Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells. J Biol Chem (1995) 0.96
Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development. Dev Genet (1995) 0.92
Factors affecting epithelial interactions. Ciba Found Symp (1987) 0.90
Scatter factor and other regulators of cell mobility. Br Med Bull (1989) 0.87
Colony assays for antibody fragments expressed in bacteria. J Immunol Methods (1991) 0.87
Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem Soc Trans (2006) 0.87
Universal cloning and direct sequencing of rearranged antibody V genes using C region primers, biotin-captured cDNA and one-side PCR. J Immunol Methods (1995) 0.85
Expression of a Cx43 deletion mutant in 3T3 A31 fibroblasts prevents PDGF-induced inhibition of cell communication and suppresses cell growth. Exp Cell Res (1999) 0.83
HGF/SF inhibits junctional communication. Exp Cell Res (1995) 0.81
Determination of the intracellular distribution and pool sizes of apolipoprotein B in rabbit liver. Biochem J (1992) 0.80
Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation. FEBS Lett (1998) 0.80
Topography of apolipoprotein B in subcellular fractions of rabbit liver probed with a panel of monoclonal antibodies. J Lipid Res (1993) 0.80
Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest (1977) 0.79
Experimental nephrotic syndrome induced in the rat by puromycin aminonucleoside: hepatic synthesis of neutral lipids and phospholipids from 3H-water and 3H-palmitate. Lipids (1980) 0.79
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. Atherosclerosis (1977) 0.79
A sensitive RNase protection assay for the quantitation of the mRNAs for the LDL receptor and HMG-CoA reductase in human total RNA. Effects of treatments on cells in culture designed to up- and down-regulate expression of the LDL receptor. Atherosclerosis (1991) 0.78
Down-regulation of scatter factor in MRC 5 fibroblasts by epithelial-derived cells. A model for scatter factor modulation. J Cell Sci (1992) 0.78
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins. Lipids (1980) 0.78
Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells. Eur J Immunol (1997) 0.77
Non-random features of the repertoire expressed by the members of one V kappa gene family and of the V-J recombination. Eur J Immunol (1992) 0.77
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. Exp Mol Pathol (1983) 0.77
Transforming growth factor-beta 1 and interleukin-1 beta stimulate LDL receptor activity in Hep G2 cells. Atherosclerosis (1992) 0.77
Membrane-bound apolipoprotein B is exposed at the cytosolic surface of liver microsomes. FEBS Lett (1992) 0.76
Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. Biochim Biophys Acta (1982) 0.76
Measurement of the absolute number of functioning low-density lipoprotein receptors in vivo using a monoclonal antibody. Biochem J (1995) 0.75
Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. Biochim Biophys Acta (1981) 0.75
Porcine smooth muscle cell-conditioned medium stimulates LDL receptor activity in Hep G2 cells. J Cell Sci (1992) 0.75
Microcirculation and hemorheology in NIDDM patients. Angiology (1990) 0.75
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins. Exp Mol Pathol (1980) 0.75
Topography of apolipoprotein B in subcellular fractions from rabbit liver. Biochem Soc Trans (1993) 0.75
Capabilities of public, voluntary and private dispensaries in basic health service provision. World Health Forum (1996) 0.75
The distribution of apolipoprotein B in endoplasmic reticulum and Golgi subfractions of rabbit liver. Biochem Soc Trans (1990) 0.75